companydata.dkcompanydata.dk

HELSEFARMA ApS: Financial statements 2022

CVR: 18394545

Source: annual report 2022, Danish Business Authority

01/01/202231/12/2022

HELSEFARMA ApS (CVR 18394545) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -50,715 and a net result of DKK -345,347 compared with DKK -915,254 the year before. Equity in the 2022 report amounted to DKK 232,252. The solvency ratio was 88.5%. The company had 1 employee in the financial year.

Gross Profit
DKK -50,715
Profit/Loss
DKK -345,347
Equity
DKK 232,252
Total Assets
DKK 262,462
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--51 t.-345 t.232 t.1
2021--36 t.-915 t.578 t.0
2020--43 t.1.2 mio.1.6 mio.0
2019--44 t.435 t.845 t.0
2018--51 t.338 t.691 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on HELSEFARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

HELSEFARMA ApS: The 2021 annual report is outJun 28, 2022

HELSEFARMA ApS has published its annual report for 2021. Gross profit came to DKK -35,506, and the net result was DKK -915,254.

About HELSEFARMA ApS

HELSEFARMA ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 1994. The company is registered under the industry Anden teknisk rådgivning. The management consists of Dorit Møller. The company is owned by Dorit Møller. The company has 0 employees (1998). In 2025, the company reported a gross profit of DKK -19,621 and a net result of DKK -86,595 compared with DKK 1,071,570 the year before. Equity in the 2025 report amounted to DKK 1,000,738.

Source: annual report 2025, Danish Business Authority